Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Nos Premenopausal”

164 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 164 results

Large-scale testing (Phase 3)UnknownNCT02132000
What this trial is testing

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Who this might be right for
Breast Cancer Patients in PremenopausalEstrogen and/or Progesterone Receptor Positive
Fengxi Su 3,036
Early research (Phase 1)Study completedNCT00976339
What this trial is testing

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Katherine D. Crew 20
Not applicableActive Not RecruitingNCT02308085
What this trial is testing

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

Who this might be right for
Early Breast Cancer
ETOP IBCSG Partners Foundation 518
Testing effectiveness (Phase 2)Study completedNCT02344550
What this trial is testing

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Asan Medical Center 137
Large-scale testing (Phase 3)Study completedNCT02483767
What this trial is testing

Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 98
Testing effectiveness (Phase 2)Ended earlyNCT00555477
What this trial is testing

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 69
Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Large-scale testing (Phase 3)Ended earlyNCT03936933
What this trial is testing

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Who this might be right for
Breast Cancer
Eurofarma Laboratorios S.A. 6
Testing effectiveness (Phase 2)Study completedNCT03844685
What this trial is testing

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88
Early research (Phase 1)Looking for participantsNCT07310420
What this trial is testing

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Who this might be right for
Advanced Breast CancerEarly Breast Cancer
TerSera Therapeutics LLC 176
Large-scale testing (Phase 3)Study completedNCT00201851
What this trial is testing

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 740
Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Not applicableStudy completedNCT07127315
What this trial is testing

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Large-scale testing (Phase 3)Study completedNCT02941926
What this trial is testing

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 3,246
Large-scale testing (Phase 3)Looking for participantsNCT05827081
What this trial is testing

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Who this might be right for
Early Breast Cancer
Novartis Pharmaceuticals 1,400
Not applicableStudy completedNCT00118508
What this trial is testing

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Who this might be right for
Osteoporosis
University of Pittsburgh 87
Not applicableActive Not RecruitingNCT05612100
What this trial is testing

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Mayo Clinic 169
Large-scale testing (Phase 3)Study completedNCT00375505
What this trial is testing

The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 70
Testing effectiveness (Phase 2)Study completedNCT03822468
What this trial is testing

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 376
Post-approval studies (Phase 4)Ended earlyNCT00333229
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Who this might be right for
Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
Novartis Pharmaceuticals 11
Next Page